Study of OCT Peripapillary Angiography in Patients With Advanced Glaucoma
NCT: NCT06274593 · RECRUITING
Brief Summary
Glaucoma is a chronic disease of the optic nerve, characterized by progressive loss of nerve cells in the retina, leading to progressive loss of peripheral and central vision. There are in fact several types of glaucoma, which is the world's second leading cause of blindness after cataracts, and the leading cause of irreversible blindness. To date, to our knowledge, there is no work analyzing the progression of angiographic OCT in patients with glaucoma. The main aim of this study is to compare the 3-year progression rate of 3 examinations in advanced glaucoma patients: one functional (visual field) and two anatomical (OCTa and OCTrnfl).
Frequently Asked Questions
What is Study of OCT Peripapillary Angiography in Patients With Advanced Glaucoma?
Study of OCT Peripapillary Angiography in Patients With Advanced Glaucoma is a clinical trial registered under NCT06274593. Current status: RECRUITING.
What is the status of NCT06274593?
The current status of NCT06274593 (Study of OCT Peripapillary Angiography in Patients With Advanced Glaucoma) is: RECRUITING.
When did Study of OCT Peripapillary Angiography in Patients With Advanced Glaucoma start?
Study of OCT Peripapillary Angiography in Patients With Advanced Glaucoma started on 2024-04-27.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.